This article was originally published in The Rose Sheet
House Appropriations Committee adds almost $5.9 mil. to FDA's fiscal year 2006 budget during a markup of the Agriculture Appropriations bill May 25. Additional funding would be used for drug safety efforts and for FDA's review of direct-to-consumer advertisements. Under the bill, FDA's 2006 budget would total $1.48 bil., which represents a $36 mil. increase over the FY 2005 level but falls $14 mil. short of President Bush's budget request. Legislation includes amendment attached by the Agriculture Subcommittee that would withhold 5% of funds from FDA's central offices until the head of the agency testifies before the panel on the President's budget request. Bill will be addressed on the House floor following a one-week Memorial Day recess. The Senate Appropriations/Agriculture Subcommittee has not yet marked up a bill...
You may also be interested in...
After double-digit growth in formulation sales across geographies in the fourth quarter, Aurobindo expects to continue the momentum this fiscal year. Meanwhile, it might look for partners for its biologics business, which is now transferred to its fully owned subsidiary for $48m.
The European Commission has updated its rolling plan. It now looks as if current member state rules for non-medical products could persist beyond the 26 May 2021 deadline.
GSK launches a 100% natural saline spray in the UK to compliment its Piri hayfever brand portfolio.